Clinical Trial Update: A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pharmacokinetics, efficacy, and safety of brivaracetam in newborns with repeated epileptiform EEG activity; the study is terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Electroencephalographic Neonatal Seizures

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Electroencephalographic Neonatal Seizures | Phase 3 | Status: TERMINATED | Results posted: 2024-01-16